trifluoperazine has been researched along with Coronary Disease in 9 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Models of ischemic and reperfusion arrhythmias were reproduced in isolated rat hearts by means of the ligation and subsequent reocclusion of the left descending coronary artery." | 5.27 | [Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine]. ( Karpov, RS; Larionov, NP; Malyshev, IIu; Meerson, FZ, 1988) |
| "Models of ischemic and reperfusion arrhythmias were reproduced in isolated rat hearts by means of the ligation and subsequent reocclusion of the left descending coronary artery." | 1.27 | [Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine]. ( Karpov, RS; Larionov, NP; Malyshev, IIu; Meerson, FZ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duncan, CJ | 1 |
| Rudge, MF | 1 |
| Sargent, CA | 1 |
| Sleph, PG | 1 |
| Dzwonczyk, S | 1 |
| Smith, MA | 1 |
| Grover, GJ | 1 |
| Sugawara, E | 1 |
| Nakayama, Y | 1 |
| Senoo, Y | 1 |
| Teramoto, S | 1 |
| Otani, H | 1 |
| Prasad, MR | 1 |
| Jones, RM | 1 |
| Das, DK | 1 |
| Meerson, FZ | 1 |
| Malyshev, IIu | 1 |
| Larionov, NP | 1 |
| Karpov, RS | 1 |
| Slezák, J | 2 |
| Tribulová, N | 1 |
| Gabauer, I | 1 |
| Ziegelhöffer, A | 1 |
| Holec, V | 1 |
| Demkow, M | 1 |
| Beresewicz, A | 1 |
| Mistarz, K | 1 |
| Zoli, I | 1 |
| Baroncini, S | 1 |
| Cornia, GL | 1 |
| Donato, S | 1 |
| Minore, G | 1 |
| Pigini, G | 1 |
| Pretolani, E | 1 |
| Amadini, S | 1 |
| Bagnoli, L | 1 |
9 other studies available for trifluoperazine and Coronary Disease
| Article | Year |
|---|---|
Trifluoperazine and the rapid, Ca2+-triggered damage of skeletal and cardiac muscle.
Topics: Animals; Calcimycin; Calcium; Coronary Disease; Dinitrophenols; Hypoxia; Mice; Muscular Diseases; Ra | 1984 |
Effect of calmodulin and protein kinase C inhibitors on globally ischemic rat hearts.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Analysis of Variance; Animals; Benzimidazo | 1992 |
Protective effects of calmodulin antagonists (trifluoperazine and W-7) on hypothermic ischemic rat hearts.
Topics: Acetylglucosaminidase; Animals; Calmodulin; Cathepsin D; Coronary Disease; Creatine Kinase; Heart; H | 1991 |
Mechanism of membrane phospholipid degradation in ischemic-reperfused rat hearts.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Coronary Disease; Fatty Acids, Nonesterified; | 1989 |
[Prevention of ischemic and reperfusion arrhythmias using the calmodulin blocker trifluoperazine].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calmodulin; Coronary Disease; In Vitro Techni | 1988 |
Diminution of injury in reperfused ischemic myocardium by phenothiazines. A quantitative morphological study.
Topics: Animals; Calmodulin; Chlorpromazine; Coronary Circulation; Coronary Disease; Dogs; Female; Male; Myo | 1987 |
[Protective effect of trifluoperazine on the ischemic myocardium].
Topics: Animals; Coronary Circulation; Coronary Disease; In Vitro Techniques; Male; Rats; Rats, Inbred Strai | 1987 |
[Therapeutic possibilities in coronary disease].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Arteriosclerosis; Cardiomegaly; Coronary Disease | 1973 |
[Clinical studies with a new anticoronaritis preparation].
Topics: Arteriosclerosis; Arteritis; Coronary Disease; Electrocardiography; Humans; Myocardial Infarction; P | 1969 |